← Back to Search

Behavioural Intervention

Virtual Reality for Abdominal Pain in Crohn's Disease

N/A
Recruiting
Led By Jami Kinnucan, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Patients with symptoms representing a known pelvic floor disorder
Patients using opioids
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to determine if patients with Crohn's disease who experience abdominal pain and reduced quality of life, even without active inflammation, can benefit from using virtual reality technology.

Who is the study for?
This trial is for individuals with Crohn's disease who are not currently experiencing active inflammation but suffer from abdominal pain that affects their quality of life. The specific eligibility criteria to join the study have not been provided.
What is being tested?
The study is testing whether a VR headset can help relieve abdominal pain in patients with quiescent Crohn's disease, aiming to improve their health-related quality of life.
What are the potential side effects?
Potential side effects from using the VR headset may include dizziness, nausea, eye strain or headaches. However, detailed side effects related to this intervention were not specified.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have symptoms of a pelvic floor disorder.
Select...
I am currently using opioids for pain management.
Select...
I have a visual or hearing impairment.
Select...
I have a known seizure disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Improvement in abdominal pain

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: VR HeadsetExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,326 Previous Clinical Trials
3,059,479 Total Patients Enrolled
Jami Kinnucan, MDPrincipal InvestigatorMayo Clinic
~8 spots leftby May 2025